New Tools and Transformative Partnerships Can Help End TB
By Dr. Mohammed Yassin – Senior TB Advisor, the Global Fund It appears new, life-changing technologies come on the scene more and more with each passing year. In November 2022, the artificial intelligence (AI) tool ChatGPT dominated global headlines; by January 2023, the digital application had more than 100 million users and dozens of imitators. […]
Global Fund – Uganda Monthly Performance Review Meeting held
The Global Fund – Uganda Monthly Performance Review meeting was held earlier this month at the Ministry of Health headquarters in Kampala. The meeting sought to review the operations of the Global Fund Grant, with the intention of improving programme implementation of the three disease areas (HIV/AIDS, TB and Malaria) and Resilient and Sustainable Systems […]
PS reiterates importance of GF Sub-recipients review meetings
The Health Ministry Permanent Secretary Dr Diana Atwine has appreciated Global Fund Sub-Recipients for their contribution towards the execution of the Global Fund grants. Dr Atwine was speaking at the Global Fund Sub-Recipients Performance Review Meeting was held recently October at Fairway Hotel. “We’re looking forward to working with you in the next grant,” Dr […]
Health Sector makes progress towards achieving targets
According to the Annual Health Sector Performance Report (AHSPR), the sector made good progress toward achieving its targets for the Financial Year 2022/23. The sector achieved 50% and made some progress in 20% of the Key Result Area indicators. The sector also achieved 46% and made progress in 8% of the outcome indicators. According to […]
LLIN campaign report highlights progress and points to strategies for completion
The latest Long-Lasting Insecticide Treated Nets (LLINs) Mass Distribution campaign status report points to some significant achievements of a 99.7% success rate in LLIN procurement. According to the report, the institutionalization of the campaign through the utilization of government structures, operating from the national level down to the village level, has been a key milestone. […]
Global Fund underscores value of collective commitment to end malaria
There is a need to optimize the value of partnerships and collective efforts toward ending malaria, according to the Global Fund High Impact Head for Africa, Mr. Linden Morrison. Mr. Morrison was speaking at the regional launch of the mosquito net distribution campaign in western Uganda at Karambi Division Headquarters in Fort Portal City. He […]
Demographic and Health survey points to infant and maternal health progress
The latest demographic and health trends survey has highlighted positive strides on Uganda’s infant and maternal health front. According to the Uganda Bureau of Statistics (Ubos), the 2022 Uganda Demographic and Health Survey (UDHS) reflected a significant reduction in pregnancy-related mortality ratios, from 368 to 228 mothers per 100,000 live births. The survey report also […]
Revised National Health Insurance Scheme proposes mandatory contribution for all adults
According to the Ministry of Health, the revised National Health Insurance Scheme will require all Ugandan adults to contribute 15,000 shillings on an annual basis. In 2021, the original National Health Insurance Bill was withdrawn by the government because of gaps that had to be addressed after stakeholder consultations. “We have done a good job […]
Global Fund announces new mechanism to increase access to more effective mosquito nets for malaria prevention
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. According to a news report published by the Global Fund on August 22nd, 2023, this financial mechanism uses advanced market commitments, including volume […]
Global Fund agreements significantly reduce price of First-line HIV treatment
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a first-line HIV treatment for under US$45 per person, per year for the first time. According to a news […]
